Skip to Main content Skip to Navigation
Journal articles

Genome sequencing for genetics diagnosis of patients with intellectual disability: the DEFIDIAG study

C Binquet 1, 2, * Catherine Lejeune 1, 2, 3 Laurence Faivre 1, 3 Marion Bouctot 2 Marie-Laure Asensio 2 Alban Simon 4 Jean-Francois Deleuze 5 Anne Boland 5 Francis Guillemin 6 Valérie Seror 7 Christelle Delmas 8 Helene Esperou 8 yannis Duffourd 1, 3 Stanislas Lyonnet 9, 10 Sylvie Odent 11, 12 Delphine Heron 13 Damien Sanlaville 14 Thierry Frebourg 15, 16 Benedicte Gerard 4 Helene Dollfus 4 
Abstract : Introduction: Intellectual Disability (ID) is the most common cause of referral to pediatric genetic centers, as it affects around 1-3% of the general population and is characterized by a wide genetic heterogeneity. The Genome Sequencing (GS) approach is expected to achieve a higher diagnostic yield than exome sequencing given its wider and more homogenous coverage, and, since theoretically, it can more accurately detect variations in regions traditionally not well captured and identify structural variants, or intergenic/deep intronic putatively pathological events. The decreasing cost of sequencing, the progress in data-management and bioinformatics, prompted us to assess GS efficiency as the first line procedure to identify the molecular diagnosis in patients without obvious ID etiology. This work is being carried out in the framework of the national French initiative for genomic medicine (Plan France Medecine Genomique 2025). Methods and Analysis: This multidisciplinary, prospective diagnostic study will compare the diagnostic yield of GS trio analysis (index case, father, mother) with the French core minimal reference strategy (Fragile-X testing, chromosomal microarray analysis and Gene Panel Strategy of 44 selected ID genes). Both strategies are applied in a blinded fashion, in parallel, in the same population of 1275 ID index cases with no obvious diagnosis (50% not previously investigated). Among them, a subgroup of 196 patients are randomized to undergo GS proband analysis in addition to GS trio analysis plus the French core minimal reference strategy, in order to compare their efficiency. The study also aims to identify the most appropriate strategy according to the clinical presentation of the patients, to evaluate the impact of deployment of GS on the families' diagnostic odyssey and the modification of their care, and to identify the advantages/difficulties for the patients and their families. Ethics Statement: The protocol was approved by the Ethics Committee Sud Mediterranee I and the French data privacy commission (CNIL, authorization 919361)
Complete list of metadata
Contributor : Admin HAL UR1 Connect in order to contact the contributor
Submitted on : Friday, May 6, 2022 - 1:02:22 PM
Last modification on : Wednesday, June 22, 2022 - 3:35:01 AM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



C Binquet, Catherine Lejeune, Laurence Faivre, Marion Bouctot, Marie-Laure Asensio, et al.. Genome sequencing for genetics diagnosis of patients with intellectual disability: the DEFIDIAG study. Frontiers in Genetics, Frontiers, 2022, 12, pp.766964. ⟨10.3389/fgene.2021.766964⟩. ⟨hal-03610031⟩



Record views


Files downloads